Inherited Risk Evaluation Tool (InheRET): Identifying Patients at Increased Risk for Hereditary Disease
Hereditary Cancer-Predisposing Syndrome
About this trial
This is an interventional prevention trial for Hereditary Cancer-Predisposing Syndrome
Eligibility Criteria
Inclusion Criteria:
- Primary Care sites:Adult patients with New and Health Maintenance Exam appointments at participating clinics
- Genetics sites: Adult patients with new referrals for genetic counseling
Exclusion Criteria:
- Patients who were previously referred or who have an appointment for genetic counseling pending.
Sites / Locations
- InheRET, Inc.
- Michigan Medicine
- Hamilton Community Health Network - withdrew from study
- Ascension St. Mary's Hospital - withdrew from study
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Pre-InheRET
Post-InheRET
Determine appropriate genetic counseling referral rates (as defined by NCCN guidelines) per patient (across all sites) in the pre-intervention 6-month period. Only referrals to Michigan Medicine (MM) genetics clinics will be included in the statistical analysis. Having access to MM health records, we will be able to assess the appropriateness of the referrals.
Determine appropriate genetic counseling referral rates (as defined by NCCN guidelines) per patient (across all sites) in the post-intervention period. Only referrals to Michigan Medicine genetics clinics will be included in the statistical analysis. Having access to MM health records, we will be able to assess the appropriateness of the referrals.